Found: 80
Select item for more details and to access through your institution.
The Eneman/Philips Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 9, p. 1212
- By:
- Publication type:
- Article
CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase-2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00123
- By:
- Publication type:
- Article
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 3, p. 487, doi. 10.1007/s10549-023-06889-0
- By:
- Publication type:
- Article
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.
- Published in:
- Nature Medicine, 2013, v. 19, n. 9, p. 1178, doi. 10.1038/nm.3289
- By:
- Publication type:
- Article
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6
- By:
- Publication type:
- Article
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 169, doi. 10.1007/s10637-014-0166-6
- By:
- Publication type:
- Article
Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 4, p. 218, doi. 10.1016/j.cllc.2011.03.022
- By:
- Publication type:
- Article
Challenges and Opportunities for Immunotherapies in Gynecologic Cancers.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 1, p. 67
- By:
- Publication type:
- Article
Expanding access to early phase trials: the CATCH-UP.2020 experience.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 1, p. 1, doi. 10.1093/jncics/pkac087
- By:
- Publication type:
- Article
Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Caboxypeptidase G<sub>2</sub>.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 20, p. 1557, doi. 10.1093/jnci/djh270
- By:
- Publication type:
- Article
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Spinal cord compression in widely metastatic Wilms' tumor. Paraplegia in two children with anaplastic Wilms' tumor.
- Published in:
- 1992
- By:
- Publication type:
- journal article
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 1, p. 126, doi. 10.1007/s10637-009-9322-9
- By:
- Publication type:
- Article
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 5, p. 677, doi. 10.1007/s10637-009-9296-7
- By:
- Publication type:
- Article
Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 2, p. 161, doi. 10.1007/s10637-006-9007-6
- By:
- Publication type:
- Article
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 563, doi. 10.1007/s10637-005-0754-6
- By:
- Publication type:
- Article
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 933, doi. 10.1007/s10549-011-1866-7
- By:
- Publication type:
- Article
INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii12, doi. 10.1093/neuonc/nou206.42
- By:
- Publication type:
- Article
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 1079, doi. 10.1093/neuonc/not082
- By:
- Publication type:
- Article
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for advanced Stage or Metastatic Solid Tumor Cancers.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00062
- By:
- Publication type:
- Article
Confronting the Care Delivery Challenges Arising from Precision Medicine.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00106
- By:
- Publication type:
- Article
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 815, doi. 10.1007/s00280-020-04176-z
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 4, p. 547, doi. 10.1007/s00280-012-1936-5
- By:
- Publication type:
- Article
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 201, doi. 10.1007/s00280-012-1859-1
- By:
- Publication type:
- Article
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 4, p. 1021, doi. 10.1007/s00280-011-1798-2
- By:
- Publication type:
- Article
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 393, doi. 10.1007/s00280-010-1331-z
- By:
- Publication type:
- Article
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 973, doi. 10.1007/s00280-010-1250-z
- By:
- Publication type:
- Article
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 73, doi. 10.1007/s00280-009-1005-x
- By:
- Publication type:
- Article
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 79, doi. 10.1007/s00280-008-0845-0
- By:
- Publication type:
- Article
A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- Report
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 851, doi. 10.1007/s00280-008-0807-6
- By:
- Publication type:
- Article
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 441, doi. 10.1007/s00280-008-0754-2
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 351, doi. 10.1007/s00280-004-0962-3
- By:
- Publication type:
- Article
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 295, doi. 10.1007/s00280-004-0871-5
- By:
- Publication type:
- Article
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00560
- By:
- Publication type:
- Article
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00573
- By:
- Publication type:
- Article
Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Brachytherapy in Puerto Rico After Hurricane Maria.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00414
- By:
- Publication type:
- Article
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00180
- By:
- Publication type:
- Article
Radiopharmaceuticals for Relapsed or Refractory Leukemias.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00097
- By:
- Publication type:
- Article
Triapine Radiochemotherapy in Advanced Stage Cervical Cancer.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00149
- By:
- Publication type:
- Article
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 476, doi. 10.1038/s41416-023-02534-1
- By:
- Publication type:
- Article